As such, cumulative STING activity within tumours is not just determined by the intrinsic cytosolic DNA burden and the expression of cGAS–STING components within cancer cells, but also by the composition of the TME and the capacity of its distinct cellular components to import and respond to cGAS–STING ligands (Figure 5b). The gene discussed is STING1; the disease is neoplasm.